Hemoglobin Vancouver [alpha2beta2(73)(E17) Asp replaced by Tyr]: its structure and function.

Area of Science:

• Hematology
• Molecular Biology
• Biochemistry

Background:

• Hemoglobin Vancouver is a newly identified abnormal hemoglobin variant.
• It involves an amino acid substitution at position 73 of the beta chain (aspartyl to tyrosyl residue).
• This variant was discovered in an individual of Chinese descent and also found in their sibling.

Purpose of the Study:

• To characterize the structural and functional properties of Hemoglobin Vancouver.
• To investigate the impact of the beta73 substitution on hemoglobin's oxygen binding and interactions.
• To compare Hemoglobin Vancouver with other known beta73 hemoglobin variants.

Main Methods:

• Amino acid analysis to identify the substitution.
• Oxygen equilibrium studies to assess oxygen affinity.
• Analysis of subunit interactions and Bohr effect.

Main Results:

• Hemoglobin Vancouver exhibits decreased oxygen affinity.
• Subunit interactions appear normal, but the Bohr effect may be slightly increased.
• This is the fourth abnormal hemoglobin identified with a substitution at the beta73 position.

Conclusions:

• The beta73 position is crucial for both intra- and intermolecular interactions within hemoglobin.
• Functional differences among beta73 variants suggest a complex role for this residue.
• Further research is warranted to fully understand the implications of beta73 substitutions in hemoglobinopathies.